LVAD Makers Must Grow Patient Pool Or Some Competitors Will Wilt
This article was originally published in The Gray Sheet
Executive Summary
FDA is unmoved by developers' pleas to relax clinical data requirements for destination ventricular assist devices so more competitors can enter the VAD market